The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Repligen Corp’s stock clocked out at $146.54, down -0.54% from its previous closing price of $147.34. In other words, the price has decreased by -$0.54 from its previous closing price. On the day, 0.52 million shares were traded. RGEN stock price reached its highest trading level at $149.32 during the session, while it also had its lowest trading level at $143.91.
Ratios:
To gain a deeper understanding of RGEN’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 10.47 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 62.55. For the most recent quarter (mrq), Quick Ratio is recorded 8.76 and its Current Ratio is at 10.44. In the meantime, Its Debt-to-Equity ratio is 0.33 whereas as Long-Term Debt/Eq ratio is at 0.33.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Canaccord Genuity on December 17, 2024, initiated with a Hold rating and assigned the stock a target price of $165.
On August 28, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $180.Wells Fargo initiated its Overweight rating on August 28, 2024, with a $180 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 21 ’24 when Hunt Anthony sold 24,246 shares for $139.67 per share. The transaction valued at 3,386,439 led to the insider holds 139,840 shares of the business.
Anthony Hunt bought 24,246 shares of RGEN for $3,386,311 on Nov 21 ’24. On Sep 10 ’24, another insider, Hunt Anthony, who serves as the Director of the company, sold 22,191 shares for $145.37 each. As a result, the insider received 3,225,927 and left with 139,840 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RGEN now has a Market Capitalization of 8210152448 and an Enterprise Value of 8140899328. For the stock, the TTM Price-to-Sale (P/S) ratio is 12.96 while its Price-to-Book (P/B) ratio in mrq is 4.07. Its current Enterprise Value per Revenue stands at 12.722 whereas that against EBITDA is 81.039.
Stock Price History:
Over the past 52 weeks, RGEN has reached a high of $211.13, while it has fallen to a 52-week low of $113.50. The 50-Day Moving Average of the stock is 1.93%, while the 200-Day Moving Average is calculated to be -3.26%.
Shares Statistics:
It appears that RGEN traded 596.99K shares on average per day over the past three months and 503610 shares per day over the past ten days. A total of 56.03M shares are outstanding, with a floating share count of 52.13M. Insiders hold about 6.96% of the company’s shares, while institutions hold 99.83% stake in the company. Shares short for RGEN as of 1732838400 were 3299852 with a Short Ratio of 5.53, compared to 1730332800 on 3300507. Therefore, it implies a Short% of Shares Outstanding of 3299852 and a Short% of Float of 6.890000000000001.
